Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 251,40 per year only 20,95 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Soucy F and Grgoire M: Efficacy of prednisone for severe refractory ulcerative interstitial cystitis
The Billon 2025 paper (PMID 41421047) is the citation that anchors the route question: SLU-PP-915 was developed because SLU-PP-332 "lacks oral bioavailability." If the parent compound does not absorb orally, oral capsules and tablets are unlikely to produce the systemic ERR agonism seen in mice
Out-of-pocket costs change often, and insurance reimbursements vary widely
It does not bind androgen, estrogen, progesterone, or glucocorticoid receptors, does not aromatize, and has no effect on the HPG or HPT axes
J Neuro-Ophthalmol 23(2):157163
US$ 23.77
US$ 23.03
US$ 23.46
US$ 25.40
US$ 29.45
US$ 20.23
US$ 21.36
